试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-01-31
Salicylic Augmentation in Depression
编号:NCT03152409登记状态:提前终止企业 / 申办者:Jessica Harder
药物 / 成分:Aspirin 325mg、Placebo Oral Tablet
登记的停止原因(原文):Inadequate resources to complete the study
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-01-31
Plasmalyte Versus Saline in Trauma Patients
编号:NCT03630224登记状态:提前终止企业 / 申办者:Assistance Publique - Hôpitaux de Paris
药物 / 成分:Plasmalyte Viaflo、NaCl 0.9%
登记的停止原因(原文):Premature termination due to futility following interim analysis
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-01-31
Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery
编号:NCT04200651登记状态:提前终止企业 / 申办者:The New York Eye Surgery Center
药物 / 成分:Dexamethasone Ophthalmic Insert、Prednisolone Acetate 1% Oph Susp
登记的停止原因(原文):COVID-19 challenges to recruitment
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-01-31
Trial Evaluating the Efficacy of the Combination of ROpivacaine With Reference XYlocaine in the Evaluation of Pain During the Installation of Percutaneous Radiological GASTrostomy
编号:NCT04250805登记状态:提前终止企业 / 申办者:Centre Hospitalier Universitaire de Saint Etienne
药物 / 成分:Lidocaine、Ropivacaine
登记的停止原因(原文):Difficulties in recruiting patients
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-01-31
Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial
编号:NCT04403282登记状态:提前终止企业 / 申办者:Walter Reed National Military Medical Center
药物 / 成分:Eflornithine Topical、Placebo Eflornithine Topical
登记的停止原因(原文):Vaniqa no longer manufactured
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-01-31
First-In-Human (FIH) Study of W0180 as Single Agent and in Combination With Pembrolizumab in Adults With Locally Advanced or Metastatic Solid Tumors
编号:NCT04564417登记状态:提前终止企业 / 申办者:Pierre Fabre Medicament
药物 / 成分:W0180、Pembrolizumab
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-01-31
The Effect of Tamsulosin on Postoperative Urinary Retention
编号:NCT04682366登记状态:提前终止企业 / 申办者:Wake Forest University Health Sciences
药物 / 成分:Tamsulosin、Placebo
登记的停止原因(原文):Challenges in enrollment led to decission for termination
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-01-31
Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery
编号:NCT04990804登记状态:提前终止企业 / 申办者:Vanderbilt University Medical Center
药物 / 成分:Opioid Analgesic、Opioid-Free Postoperative Pain Regimen
登记的停止原因(原文):Limitations of the prospective study design revealed that a retrospective study design would be better suited.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-01-31
PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies
编号:NCT05107856登记状态:提前终止企业 / 申办者:Prelude Therapeutics Incorporated
药物 / 成分:PRT1419、Azacitidine、Venetoclax
登记的停止原因(原文):Company Decision
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-01-31
Pharmacokinetics of Colistin in Critically Ill Patients With Extracorporeal Membrane Oxygenation
编号:NCT05542446登记状态:提前终止企业 / 申办者:St. Anne's University Hospital Brno, Czech Republic
药物 / 成分:Colistin
登记的停止原因(原文):After agreement between sponsor and investigator, insufficient patients recruitment
查看官方原始记录 ↗